vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Koppers Holdings Inc. (KOP). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $432.7M, roughly 1.9× Koppers Holdings Inc.). Koppers Holdings Inc. runs the higher net margin — 6.9% vs 0.5%, a 6.3% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs -9.3%). Over the past eight quarters, Acadia Healthcare Company, Inc.'s revenue compounded faster (2.0% CAGR vs -6.7%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Koppers is a global chemical and materials company based in Pittsburgh, Pennsylvania, United States. Its headquarters is an art-deco 1920s skyscraper, the Koppers Tower.
ACHC vs KOP — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $432.7M |
| Net Profit | $4.5M | $29.7M |
| Gross Margin | — | 25.6% |
| Operating Margin | — | 11.5% |
| Net Margin | 0.5% | 6.9% |
| Revenue YoY | 7.5% | -9.3% |
| Net Profit YoY | -50.8% | 391.2% |
| EPS (diluted) | $0.05 | $1.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $432.7M | ||
| Q3 25 | $851.6M | $485.3M | ||
| Q2 25 | $869.2M | $504.8M | ||
| Q1 25 | $770.5M | $456.5M | ||
| Q4 24 | $774.2M | $477.0M | ||
| Q3 24 | $815.6M | $554.3M | ||
| Q2 24 | $796.0M | $563.2M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $29.7M | ||
| Q3 25 | $36.2M | $23.8M | ||
| Q2 25 | $30.1M | $16.4M | ||
| Q1 25 | $8.4M | $-13.9M | ||
| Q4 24 | $32.6M | $-10.2M | ||
| Q3 24 | $68.1M | $22.8M | ||
| Q2 24 | $78.5M | $26.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 25.6% | ||
| Q3 25 | — | 24.1% | ||
| Q2 25 | — | 22.6% | ||
| Q1 25 | — | 23.2% | ||
| Q4 24 | — | 17.5% | ||
| Q3 24 | — | 21.9% | ||
| Q2 24 | — | 21.6% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 11.5% | ||
| Q3 25 | 4.7% | 10.7% | ||
| Q2 25 | 5.8% | 7.7% | ||
| Q1 25 | 1.7% | 5.9% | ||
| Q4 24 | 4.9% | 1.3% | ||
| Q3 24 | 12.1% | 9.0% | ||
| Q2 24 | 13.4% | 10.2% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 6.9% | ||
| Q3 25 | 4.3% | 4.9% | ||
| Q2 25 | 3.5% | 3.2% | ||
| Q1 25 | 1.1% | -3.0% | ||
| Q4 24 | 4.2% | -2.1% | ||
| Q3 24 | 8.4% | 4.1% | ||
| Q2 24 | 9.9% | 4.8% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $1.44 | ||
| Q3 25 | $0.40 | $1.17 | ||
| Q2 25 | $0.33 | $0.81 | ||
| Q1 25 | $0.09 | $-0.68 | ||
| Q4 24 | $0.36 | $-0.47 | ||
| Q3 24 | $0.74 | $1.09 | ||
| Q2 24 | $0.85 | $1.25 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | — |
| Total DebtLower is stronger | $2.5B | $928.3M |
| Stockholders' EquityBook value | $2.0B | $574.0M |
| Total Assets | $5.5B | $1.9B |
| Debt / EquityLower = less leverage | 1.29× | 1.62× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | — | ||
| Q3 25 | $118.7M | — | ||
| Q2 25 | $131.4M | — | ||
| Q1 25 | $91.2M | — | ||
| Q4 24 | $76.3M | — | ||
| Q3 24 | $82.1M | — | ||
| Q2 24 | $77.2M | — |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $928.3M | ||
| Q3 25 | $2.3B | $932.9M | ||
| Q2 25 | $2.3B | $977.5M | ||
| Q1 25 | $2.2B | $989.0M | ||
| Q4 24 | $2.0B | $939.5M | ||
| Q3 24 | $1.9B | $989.4M | ||
| Q2 24 | $1.8B | $1.0B |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $574.0M | ||
| Q3 25 | $3.1B | $545.6M | ||
| Q2 25 | $3.1B | $526.8M | ||
| Q1 25 | $3.0B | $498.0M | ||
| Q4 24 | $3.1B | $488.7M | ||
| Q3 24 | $3.0B | $532.3M | ||
| Q2 24 | $3.0B | $509.2M |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $1.9B | ||
| Q3 25 | $6.4B | $1.9B | ||
| Q2 25 | $6.3B | $1.9B | ||
| Q1 25 | $6.1B | $1.9B | ||
| Q4 24 | $6.0B | $1.9B | ||
| Q3 24 | $5.9B | $2.0B | ||
| Q2 24 | $5.7B | $1.9B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 1.62× | ||
| Q3 25 | 0.74× | 1.71× | ||
| Q2 25 | 0.74× | 1.86× | ||
| Q1 25 | 0.72× | 1.99× | ||
| Q4 24 | 0.64× | 1.92× | ||
| Q3 24 | 0.62× | 1.86× | ||
| Q2 24 | 0.62× | 1.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $45.1M |
| Free Cash FlowOCF − Capex | — | $28.5M |
| FCF MarginFCF / Revenue | — | 6.6% |
| Capex IntensityCapex / Revenue | — | 3.8% |
| Cash ConversionOCF / Net Profit | 13.78× | 1.52× |
| TTM Free Cash FlowTrailing 4 quarters | — | $67.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $45.1M | ||
| Q3 25 | $73.2M | $49.6M | ||
| Q2 25 | $133.5M | $50.5M | ||
| Q1 25 | $11.5M | $-22.7M | ||
| Q4 24 | $116.7M | $74.7M | ||
| Q3 24 | $163.1M | $29.8M | ||
| Q2 24 | $171.1M | $27.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $28.5M | ||
| Q3 25 | $-63.0M | $37.6M | ||
| Q2 25 | $-34.2M | $38.4M | ||
| Q1 25 | $-163.2M | $-37.0M | ||
| Q4 24 | $-86.8M | $56.1M | ||
| Q3 24 | $-27.1M | $14.4M | ||
| Q2 24 | $16.9M | $10.1M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 6.6% | ||
| Q3 25 | -7.4% | 7.7% | ||
| Q2 25 | -3.9% | 7.6% | ||
| Q1 25 | -21.2% | -8.1% | ||
| Q4 24 | -11.2% | 11.8% | ||
| Q3 24 | -3.3% | 2.6% | ||
| Q2 24 | 2.1% | 1.8% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 3.8% | ||
| Q3 25 | 16.0% | 2.5% | ||
| Q2 25 | 19.3% | 2.4% | ||
| Q1 25 | 22.7% | 3.1% | ||
| Q4 24 | 26.3% | 3.9% | ||
| Q3 24 | 23.3% | 2.8% | ||
| Q2 24 | 19.4% | 3.0% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 1.52× | ||
| Q3 25 | 2.02× | 2.08× | ||
| Q2 25 | 4.43× | 3.08× | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | — | ||
| Q3 24 | 2.39× | 1.31× | ||
| Q2 24 | 2.18× | 1.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
KOP
| Other | $127.8M | 30% |
| Railroad Treated Products | $119.0M | 28% |
| Utility Poles | $79.8M | 18% |
| Pitch And Related Products | $74.1M | 17% |
| Carbon Black Feedstock And Distillates | $14.4M | 3% |
| Railroad Infrastructure Products And Services | $9.9M | 2% |
| Phthalic Anhydride Naphthalene And Other Chemicals | $7.7M | 2% |
